No association of chromatin-modifying protein 2B with sporadic frontotemporal dementia

Axel Schumacher, Patricia Friedrich, Janine Diehl-Schmid, Bernd Ibach, Tamara Eisele, Simon M. Laws, Hans Förstl, Alexander Kurz, Matthias Riemenschneider

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Mutations of the chromatin modifying protein 2B gene (CHMP2B) were identified, in a Danish pedigree, to cause familial frontotemporal dementia (FTD). To explore the possible genetic contribution of common CHMP2B variants in sporadic FTD, we analyzed 14 single nucleotide polymorphisms covering the entire genomic region of CHMP2B. After adjustment for multiple testing single marker and haplotype analysis revealed no significant association with sporadic FTD. Thus, we conclude that CHMP2B can be excluded as a susceptibility gene conferring risk to sporadic forms of FTD.

Original languageEnglish
Pages (from-to)1789-1790
Number of pages2
JournalNeurobiology of Aging
Volume28
Issue number11
DOIs
StatePublished - Nov 2007

Keywords

  • Association study
  • CHMP2B
  • Frontotemporal dementia
  • Genetic analysis
  • POU1F1

Fingerprint

Dive into the research topics of 'No association of chromatin-modifying protein 2B with sporadic frontotemporal dementia'. Together they form a unique fingerprint.

Cite this